| Bioactivity | Atrial Natriuretic Peptide (ANP) (1-28), rat (TFA) is a major circulating form of ANP in rats, potently inhibits Angiotensin II (Ang II)-stimulated endothelin-1 secretion in a concentration-dependent manner. | ||||||
| Invitro | Rat ANP (1-28) and rat BNP-45, which are the respective major circulating forms of ANP and BNP in rats, potently inhibited Ang II-stimulated endothelin-1 secretion in a concentration-dependent manner. Rat ANP (5-25) is less effective that Rat ANP(1-28) with respect to inhibiting immunoreactive (ir)-endothelin-1 secretion and increasing cellular cyclic GMP. Rat ANP (1-28) inhibits the secretion of ir-endothelin-1 in a concentration-dependent manner between 0.01 and 1 μM[1]. | ||||||
| Name | Atrial Natriuretic Peptide (ANP) (1-28), rat TFA | ||||||
| Formula | C130H206N45F3O41S2 | ||||||
| Molar Mass | 3176.43 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Atrial Natriuretic Peptide (ANP) (1-28), rat TFA
CAS: F: C130H206N45F3O41S2 W: 3176.43
Atrial Natriuretic Peptide (ANP) (1-28), rat (TFA) is a major circulating form of ANP in rats, potently inhibits Angiote
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.